Ensysce Biosciences Inc., a clinical phase drug development company with innovative technologies to curb prescription drug abuse and overdose, today announced D. Lynn Kirkpatrick, Ph.D., Chief Executive Officer, will present at the upcoming 19th Annual Pain Therapeutics Conference in London UK.
May 10, 2019
· 2 min read